Open Orphan #ORPH – Article Published in Drug Discovery Today
Open Orphan (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organization (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces an article submission has been published in Drug Discovery Today, a print and online trade magazine with an emphasis on the science which underpins drug discovery […]
Open Orphan #ORPH – Expansion of volunteer recruitment centres for human challenge trials
Open Orphan (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and the world leader in vaccine and antiviral testing using human challenge clinical trials, has opened two new volunteer recruitment centres to screen potential trial volunteers, the first in East London and a second in central Manchester. These new locations are […]
Alan Green discusses ESG and renewables, plus British Honey Co #BHC, Open Orphan #ORPH & Itaconix #ITX on UK Investor Magazine podcast
Alan Green discusses ESG and renewables, plus British Honey Co #BHC, Open Orphan #ORPH & Itaconix #ITX with Jonathan Roy on the UK Investor Magazine podcast
Open Orphan #ORPH – First volunteer dosed in intranasal COVID-19 vaccine clinical trial
Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services CRO and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces that the first volunteer has been dosed with the Codagenix Inc. (“Codagenix”) needle free, intranasal COVID-19 vaccine, COVI-VAC. Conducted by hVIVO, part of Open Orphan plc, the Phase I […]
Open Orphan #ORPH – Contract renewal with top-3 global pharmaceutical client
Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services CRO and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces a further contract renewal with a major top-3 global pharmaceutical client extending its consultancy services to end of December 2021. This follows on from the announcement made on […]
Alan Green talks Open Orphan #ORPH, Blue Prism #PRSM & Power Metal Resources #POW on Vox Markets podcast
Alan Green discusses Open Orphan #ORPH, Blue Prism #PRSM & Power Metal Resources #POW on Vox Markets podcast. Interview is 32 minutes 34 seconds in.
Daily Mail – The volunteers who are DELIBERATELY catching Covid: 2,500 Britons will take part in the world’s first ‘human challenge trials’ run by Imperial College next month in bid to accelerate research on pandemic
by Faith Ridler The volunteers who are DELIBERATELY catching Covid: 2,500 Britons will take part in the world’s first ‘human challenge trials’ run by Imperial College next month in bid to accelerate research on pandemic Alex Greer, 20, will take part in the human challenge trials in London next month Those in the study will […]
Open Orphan #ORPH – Successful completion of PrEP Biopharm Toxicology study for respiratory ‘viral mimic’
Phase IIb study to validate efficacy of PrEP-001 against circulating respiratory viruses such as COVID-19, flu and the common cold Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services CRO which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, announces that drug development company PrEP Biopharm […]
Open Orphan #ORPH – Successful extension of contract with top-3 global pharmaceutical client underpins 2021 revenue growth expectations
Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services CRO and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces a contract renewal extending its consultancy services with a major top-3 global pharmaceutical client to December 2021. Through the Venn Life Sciences team in the Breda office in […]
Open Orphan #ORPH Chairman Cathal Friel talks to Ian King, Sky News about the Codagenix nasal Covid-19 vaccine phase I study
Open Orphan #ORPH Chairman Cathal Friel talks to Ian King, Sky News about the Codagenix nasal Covid-19 vaccine phase I study, which has received regulatory approval. Tests start at the hVIVO Whitechapel facility in the new year. Cathal explains the simplicity, ease of application of the nasal application, and looks at the history of hVIVO’s […]